About Us
A Century of Service to Public Health
Starting as Egypt's first biological laboratory, VACSERA has evolved into a national biomanufacturing champion safeguarding public health.
Vision
To achieve national self-sufficiency in serums and vaccines by expanding local production both quantitatively and qualitatively, adhering to international quality standards to obtain WHO accreditation, and keeping pace with global technological advancements.
Mission
Securing the country's needs for human and veterinary serums and vaccines, biotechnological medicines, blood and its derivatives, reagents and medical supplies.
Leadership
Dr. Sherif El-Fil
Executive Managing Director of the Holding Company for Biological Products and Vaccines
VACSERA's investments in localizing vaccine production in Egypt, research and development, infrastructure, and workforce development embody a sustainable future vision for healthcare, ensuring Egypt’s current and future needs. It contributes to building a healthcare system that creates a legacy for future generations and supports the vaccine industry from its early stages, enhancing access to high-quality vaccines across the Middle East and Africa.
Certificates & Accreditations
Committed to the highest global quality and safety benchmarks in biological production.
WHO GMP Compliance
Adhering to the World Health Organization guidelines for sterile biological production.
ISO 9001:2015
International standard for premium Quality Management System across all processes.
ISO 14001:2015
Environmental Management System supporting green and sustainable bio-industrial operations.
ISO 45001:2018
Occupational Health and Safety management keeping our biological research staff safe.
Our History
Our timeline of scientific achievements and expansion.
Establishment of a small laboratory under the Health Department
First production of smallpox vaccine in Egypt
Establishment of the General Administration of Laboratories
First production of rabies vaccine
Establishment of laboratories in Agouza for production of smallpox, typhoid, and tetanus vaccines
Establishment of Fouad I Laboratory for Serum and Vaccine in Agouza
Addition of King Farouk Laboratory for Biological Products and production of cholera vaccine
Establishment of the first central blood bank in Egypt and a laboratory animal farm in Agouza
Establishment of the animal breeding farm in Helwan
Establishment of the Egyptian General Authority for Biological Products & Vaccines in Agouza
Transformation into an economic public authority (Decree No. 1039)
Transformation into a Holding Company with 5 subsidiaries (Presidential Decree No. 187/2002)
Re-evaluation and merger of subsidiaries to form 3 core subsidiary companies
Frequently Asked Questions
Scientific and verified answers to common inquiries.